Unknown

Dataset Information

0

Influence of c-Src on hypoxic resistance to paclitaxel in human ovarian cancer cells and reversal of FV-429.


ABSTRACT: SRC family kinase was documented to have vital roles in adjusting cancer cell malignant behaviors. To date, the role of c-Src, a member of SRC family kinase, in resistance to paclitaxel in human ovarian cancer cells under hypoxia has not been investigated. In the present study, we discovered that hypoxic environment suppressed paclitaxel-induced G2/M phase arrest and blockade of c-Src improved ovarian cancer cells' sensitivity to paclitaxel. FV-429, a derivative of natural flavonoid wogonin, could suppress gene expression and activation of c-Src, followed by deteriorated Stat3 nuclear translocation and its binding to HIF-1?, resulting in paclitaxel resistance reversal through G2/M arrest potentiation. Our study demonstrated that c-Src contributed to hypoxic microenvironment-rendered paclitaxel resistance in human epithelial ovarian cancer cells by G2/M phase arrest deterioration, and through c-Src suppression, FV-429 was capable of reversing the resistance by blocking c-Src/Stat3/HIF-1? pathway.

SUBMITTER: Guo Q 

PROVIDER: S-EPMC5827169 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Influence of c-Src on hypoxic resistance to paclitaxel in human ovarian cancer cells and reversal of FV-429.

Guo Qinglong Q   Lu Lu L   Liao Yan Y   Wang Xiaoping X   Zhang Yi Y   Liu Yicheng Y   Huang Shaoliang S   Sun Haopeng H   Li Zhiyu Z   Zhao Li L  

Cell death & disease 20180111 1


SRC family kinase was documented to have vital roles in adjusting cancer cell malignant behaviors. To date, the role of c-Src, a member of SRC family kinase, in resistance to paclitaxel in human ovarian cancer cells under hypoxia has not been investigated. In the present study, we discovered that hypoxic environment suppressed paclitaxel-induced G2/M phase arrest and blockade of c-Src improved ovarian cancer cells' sensitivity to paclitaxel. FV-429, a derivative of natural flavonoid wogonin, cou  ...[more]

Similar Datasets

| S-EPMC5520180 | biostudies-literature
| S-EPMC5601152 | biostudies-literature
| S-EPMC5080661 | biostudies-literature
| S-EPMC2517641 | biostudies-literature
| S-EPMC4502659 | biostudies-literature
| S-EPMC7806986 | biostudies-literature
| S-EPMC2820594 | biostudies-literature
| S-EPMC7542453 | biostudies-literature
| S-EPMC7284978 | biostudies-literature
| S-EPMC7200223 | biostudies-literature